If you are weighing silicone vs saline breast implants, the main difference is what fills the implant: a sterile saltwater solution or silicone gel. Both have a silicone outer shell.
This page is part of the wider guide to breast reconstruction, and it looks only at how the two fill types differ. It is general information from public health sources, and decisions about surgery and recovery belong with the reader’s own surgeon and care team.
| Item | In brief |
|---|---|
| Saline-filled implant | Silicone outer shell filled with sterile saltwater solution. |
| Silicone gel-filled implant | Silicone outer shell filled with silicone gel. |
| Saline implant rupture | Saline leaks out and deflates the implant, so it is noticed. |
| Silent rupture | Usually does not change how an implant looks or feels. |
| Saline implants in reconstruction | Approved for breast reconstruction in women of any age. |
| Implant lifespan | Breast implants are not lifetime devices. |
This summary is drawn from the FDA pages on types of breast implants and risks and complications; this information can change, so check the sources for the latest version.
What each implant is made of
According to the US Food and Drug Administration (FDA), saline-filled breast implants contain a silicone outer shell filled with a sterile saltwater (saline) solution. The same page explains that some of them come pre-filled, while others are filled during the implant operation. That detail matters because an implant filled during surgery can be adjusted as the operation proceeds, whereas a pre-filled implant arrives at a fixed volume.
Silicone gel-filled implants are built differently inside. The FDA describes them as having a silicone outer shell that is filled with silicone gel. Both types are made in different sizes, and both can have smooth or textured shells, so the fill material is only one of several decisions that shape the final choice.
In reconstruction, either type may be placed after the chest tissue has been prepared. How that preparation works, including the staged approach and the direct approach, is covered in the page on implant-based breast reconstruction.
Approved uses and age limits
Regulators set age limits that differ by fill type for cosmetic augmentation, and they treat reconstruction separately. The FDA states that saline-filled breast implants are approved for breast augmentation in women age 18 or older and for breast reconstruction in women of any age. For silicone, the same source says that silicone gel-filled breast implants are approved for breast augmentation in women age 22 or older and for breast reconstruction in women of any age.
For a reader focused on rebuilding the breast after cancer surgery, the practical point is that neither fill type is restricted by age in the reconstruction setting. Both are also used in revision surgeries, which correct or improve the result of an original operation.
Side-by-side comparison
| Feature | Saline-filled | Silicone gel-filled |
|---|---|---|
| Outer shell | Silicone | Silicone |
| Filling | Sterile saltwater solution | Silicone gel |
| Shell surface | Smooth or textured | Smooth or textured |
| Rupture is noticed | Usually quickly, as the implant deflates | Often silently, without symptoms |
| Imaging for rupture | Not needed to spot deflation | MRI or ultrasound may be recommended |
The table summarises the FDA’s descriptions in its overview of implant types and its page on risks and complications.
How a rupture shows up in each type
The clearest practical difference between the two is what happens if the shell fails. For saline, the FDA says that you and your doctor will be able to tell if a saline-filled implant ruptures because the saline solution leaks into the body immediately or over several days and deflates the implant. The person usually notices the implant losing its original size or shape. The body absorbs the saltwater, and the term deflation is used only for saline-filled implants.
Silicone gel behaves differently. The same page notes that a silent rupture usually does not change the way an implant looks or feels, and a surgeon or health care provider may not be able to detect it by a physical examination alone. For that reason, the FDA says magnetic resonance imaging (MRI) is the most effective method for detecting silent rupture of silicone gel-filled breast implants, and it adds that ultrasound is an acceptable alternative imaging for screening for rupture for asymptomatic patients.
This difference is the reason follow-up looks different. Someone with silicone gel-filled implants may be advised to have periodic imaging, while someone with saline-filled implants would usually see the problem for themselves.
Costs of follow-up and long-term care
Ongoing monitoring has practical implications. In its list of things to consider, the FDA says that people with silicone gel filled breast implants may be advised by their health care provider to have regular exams using MRI or ultrasound that may not be covered by their insurance. Coverage rules differ between places and plans, so a person weighing this factor can ask the care team what imaging schedule would apply and who pays for it.
The same FDA page warns that even if complications occur, the cost of implant removal or replacement may not be covered by insurance. Neither fill type is a single purchase that ends the process, and both belong to a longer relationship with the surgical team.
Shared risks and what lasts
Most of the major concerns apply to both fill types rather than separating them. The FDA states plainly that breast implants are not lifetime devices, and that the longer a woman has implants, the more likely it is that she will need surgery to remove or replace them. The most frequent complications it lists are capsular contracture, reoperation, and implant removal, with or without replacement.
Capsular contracture is scar tissue that forms around the implant and squeezes it. Other common complications named by the FDA include rupture, wrinkling, asymmetry, scarring, pain and infection. When a replacement or correction is needed, the process is described in the page on breast reconstruction revision surgery.
On long-term safety questions, the FDA reports that there is no apparent association between saline- and silicone gel-filled breast implants and connective tissue disease, breast cancer or reproductive problems. It cautions that studies would need to be much larger and longer than those conducted so far to rule these out.
Questions that help the decision
The fill type is rarely chosen in isolation. The FDA says a surgeon should be able to discuss whether a patient is a good candidate for breast implants, the different types of implants, options for size, shape, surface texture and placement based on particular circumstances, and the risks and benefits of implant surgery. For reconstruction, the same page adds that chemotherapy or radiation therapy can affect complication risks and the appearance of the reconstructed breast.
Useful questions to bring to a consultation, drawn from the FDA’s published list, include which implant type the surgeon uses and what experience they have with each, what the most common complication is, why one type is recommended over another, and how long the implants are expected to last. The FDA also suggests asking for the patient labeling for the specific implant, which includes a boxed warning and a patient decision checklist.
Frequently asked questions
Are silicone and saline implants both used after mastectomy?
Show answer
Yes. The FDA says both saline-filled and silicone gel-filled implants are approved for breast reconstruction in women of any age.
Which type is noticed first if it ruptures?
Show answer
Saline-filled implants deflate as the saltwater leaks out, so the change is usually visible. Silicone gel ruptures are often silent and may need MRI or ultrasound to find.
Do implants last a lifetime?
Show answer
No. The FDA states that breast implants are not lifetime devices, and the longer they stay in place, the more likely removal or replacement becomes.
Can the choice be made without a surgeon?
Show answer
The type, size, shape, surface and placement all depend on personal circumstances, so the FDA expects these to be discussed in a consultation with the surgeon and care team.
